- Supported exchanges /
- ST /
- NANEXA.ST
Nanexa AB (NANEXA ST) stock market data APIs
Nanexa AB (publ) operates as a nanotechnology drug delivery company. It operates PharmaShell, a nanobased drug delivery platform that is an atomic layer deposition. The company also develops NEX-18, which drives the development of a PharmaShell that targets myelodysplastic Syndrome and Acute Myeloid Leukemia; NEX-20 for the treatment of multiple myeloma; and NEX-22 for the treatment of type 2 diabetes. Nanexa AB (publ) was founded in 2007 and is based in Uppsala, Sweden.
Nanexa AB Financial Data Overview
| 1.745 | |
| 1.345 | |
| - | |
| 1.625 | |
| 0.75 | |
| 0.6-2.02 | |
| 178 M | |
| 136 M | |
| 51 088 K | |
| -0.0327 | |
| 1.788 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Nanexa AB Fundamental Data is available in our Financial Data APIs
- Net Revenue 51 088 K
- EBITDA -62 614 000
- Earnings Per Share -0.77
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Nanexa AB Earnings via APIs
- Latest Release 2024-11-07
- EPS/Forecast NaN
Get Nanexa AB End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
